Target Structural Analysis for TPD Development
* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.
Targeted protein degradation works by hijacking the cell's ubiquitin-proteasome system, which means every decision a medicinal chemist makes (warhead choice, linker attachment, E3 ligase pairing) eventually comes back to the three-dimensional shape of the target. That is why target structural analysis sits at the very beginning of a TPD program, not at the end. BOC Sciences provides a complete target structural analysis service for TPD development, combining in vitro structure determination, computational modeling, and biology-driven interpretation to help research teams understand what a target really looks like, where a warhead can sit, and how the protein might behave once a degrader is on board. Our structural insights feed directly into degrader design, lead optimization, and downstream mechanistic studies, so the data we deliver is built to be used, not just archived.
Request a Consultation Explore ServicesServices
BOC Sciences Target Structural Analysis Services for TPD Development
Target Protein 3D Structure Determination
We resolve high-resolution target structures using crystallography, cryo-EM, MicroED, NMR, and SAXS. Each method is selected according to sample behavior, target size, and the structural question being asked, giving teams a reliable experimental baseline before any degrader chemistry begins.
- X-ray, cryo-EM, MicroED, NMR and SAXS as available routes
- Target protein services from expression through crystallization
- Atomic-level maps for warhead, linker and ternary modeling
Target Protein Structure Prediction and Modeling
When an experimental structure is missing, slow to produce, or limited to a single domain, we build high-quality protein structure models to fill the gap. Predicted structures are evaluated, refined, and cross-checked so they can be trusted for downstream docking and degrader design.
- Ab initio and homology-based structure prediction
- AI-based protein structure prediction and template-driven modeling
- Model quality scoring and refinement workflows
Protein Domain and Structural Feature Analysis
Not every part of a target is equally useful for degrader design. We map domains, motifs, and functional surfaces so the team knows which regions support ligand binding, which are flexible, and which are likely to behave poorly in a ternary complex.
- Domain boundaries, secondary structure and motif mapping
- Functional site and regulatory surface annotation
- Flexible loop and disordered region identification
Ligand-Binding Pocket Identification and Analysis
We locate and characterize binding pockets that can host a warhead, including cryptic or allosteric sites that only become visible when the protein moves. Pocket geometry, residue composition, and druggability indicators are summarized to guide hit-finding and ligand design for target protein.
- Orthosteric, allosteric and cryptic pocket mapping
- Druggability scoring and pocket comparison
- Entry vectors and attachment-point analysis
Target Protein Conformational Dynamics Analysis
Targets are not static, and degrader performance often depends on which conformational state the warhead can capture. We use molecular dynamics simulation, ensemble refinement, and HDX-MS data to describe the relevant states and transitions.
- Conformational ensemble and state distribution analysis
- Allosteric communication and dynamics pathway mapping
- HDX-MS and cross-linking MS integration where useful
Target Protein Mutation and Structural Variant Analysis
Resistance mutations, splice variants, and disease-associated point mutations can change degrader behavior overnight. We compare wild-type and variant structures to predict whether existing ligands will still engage, and where redesign may be required.
- Point mutation, insertion and deletion impact analysis
- Resistance and selectivity-related variant interpretation
- Side-by-side structural comparison and redesign hints
Need a Clear Structural Picture of Your TPD Target?
From binding pocket mapping to surface lysine analysis, we turn target structure into decisions a medicinal chemist can actually use.
Technologies
Technologies and Methods for Target Structural Analysis
Experimental and computational methods answer different structural questions. BOC Sciences selects one approach or combines both based on protein properties, sample availability, required detail, and whether the primary objective is to determine a structure or to interpret existing evidence.
Experimental Target Structural Analysis
Experimental methods provide direct structural evidence, ranging from detailed three-dimensional models to measurements of protein shape and conformational changes.
- X-ray crystallography and co-crystallization: Resolve suitable protein structures and, when feasible, ligand-bound states through co-crystallization studies.
- Cryo-electron microscopy: Investigate suitable large proteins, assemblies, and challenging complexes using cryo-EM methods.
- NMR spectroscopy: Examine suitable soluble proteins, local environments, and dynamics through NMR analysis.
- HDX-MS and SAXS: Probe changes in solvent protection or overall solution shape as complementary structural measurements, rather than stand-alone atomic-resolution methods.
Computational Target Structural Analysis
Computational approaches help explore proteins lacking complete structures, compare alternative conformations, and develop hypotheses for targeted experiments.
- Structure prediction and comparative modeling: Build protein or domain models and assess confidence in regions relevant to TPD design.
- Pocket detection and structural comparison: Identify candidate cavities, compare isoforms or related targets, and examine local chemical environments.
- Protein-ligand modeling: Explore plausible orientations through molecular docking for protein-ligand analysis, while treating predictions as hypotheses for validation.
- Conformational sampling: Analyze domain motions, loop flexibility, and possible pocket opening through appropriate simulation strategies.
Integrated interpretation: A predicted model can guide construct selection and experimental planning; experimental findings can then test or refine the model. Neither approach is chosen solely because it is newer or more complex.
Not Sure Which Structural Method Fits Your Target?
Our team can assess your available samples, structural information, and research question to propose an experimental, computational, or combined strategy.
Target Classes
Target Protein Classes for Structural Analysis in TPD Development
Different protein families present different structural opportunities and limitations. We tailor the analysis to the relevant domain, conformational state, and TPD modality rather than applying one structure determination strategy to every target.
Protein Kinases and Other Enzymatic Targets
Analyze catalytic domains, ligand-binding clefts, activation-related conformations, and selectivity-relevant residues. Structural comparisons can reveal where a ligand may retain recognition while allowing a solvent-exposed linker attachment.
- ATP- or substrate-binding pocket analysis
- Active-state and inactive-state structural comparison
Transcription Factors and Regulatory Proteins
Focus on structured DNA-binding or regulatory domains, protein interaction regions, and flexible segments. For highly disordered regions, characterization may rely on domain-level models or ensemble-based methods rather than a single complete structure.
- Structured domain and interaction-surface mapping
- Flexible-region and construct feasibility assessment
Epigenetic and Chromatin-Associated Proteins
Study bromodomains, reader domains, and other recognition modules involved in chromatin regulation. We examine conserved pockets and structural differences that may matter for target-ligand selectivity.
- Recognition-pocket and domain comparison
- Isoform and family-member structural alignment
Nuclear Receptors
Evaluate ligand-binding domains, conformational changes, and regulatory surfaces that can influence ligand recognition and degrader design. The selected receptor state is important when interpreting pocket accessibility.
- Ligand-binding domain characterization
- Conformation-dependent pocket analysis
Scaffold and Adaptor Proteins
Characterize modular interaction domains, exposed binding grooves, and the relative orientation of functional regions. These targets may require attention to partner-dependent conformations and multi-domain flexibility.
- Protein interaction interface mapping
- Multi-domain architecture and flexibility analysis
Membrane and Membrane-Associated Proteins
Assess accessible extracellular, transmembrane, or intracellular regions according to target topology. Structural feasibility depends on membrane environment, stability, and the intended degradation mechanism.
- Domain topology and exposed-region assessment
- Structure preparation strategies for membrane-associated targets
Working With a Difficult or Unusual Protein Target?
Tell us the protein class, available construct, and known challenges. We can tailor structural analysis to the features that matter for your degrader project.
Significance
Why Target Structural Analysis Matters for TPD Development?
Targeted protein degradation behaves differently from traditional inhibition. The molecule is not trying to block a function; it is trying to bring two proteins together, induce a productive geometry, and let the cellular machinery do the rest. Without structural insight, every degrader decision is essentially a guess. Target structural analysis gives chemistry and biology teams a shared picture of what they are designing against, which is what makes the rest of the program faster and less wasteful.
Identify Potential Binding Sites for Targeted Degrader Design
A degrader can only work if a warhead can engage the target in a way that still allows an E3 ligase to come close. Structural analysis distinguishes pockets that support clean ternary complex formation from those that look ligandable on paper but are not useful for degradation. This avoids spending chemistry effort on series that will never deliver the right geometry.
Guide Target Ligand and Linker Design
Knowing the exact orientation of a bound ligand tells the team where a linker can leave the pocket without clashing with the protein. Combined with our linker binding site selection and design expertise, structural analysis turns warhead hits into realistic starting points for bifunctional molecule construction.
Assess Structural Features Relevant to Target Degradation
Not every lysine on a protein surface is equally useful for ubiquitin transfer. Structural analysis identifies exposed, geometrically favorable lysines and maps the regions where cooperative PPIs are most likely. These features directly influence degrader efficiency and the choice of E3 ligase recruiter.
Reduce Trial-and-Error in Degrader Optimization
Degrader optimization is slow when each SAR cycle depends on full cellular degradation readouts. Structural analysis shortens this loop by predicting which warhead changes, linker modifications, or E3 swaps are worth testing first, cutting down the number of compounds that need to be made and profiled.
Workflow
Our Target Structural Analysis Workflow
Every TPD program starts somewhere, and not every starting point looks the same. Some teams have a crystallized target and a clear E3 ligase in mind. Others only have a sequence and a hypothesis. Our workflow is built to accept either, to flag what is missing early, and to deliver a structural package that fits the stage the project is actually in.
01
Project Consultation and Target Structure Review
We start by reviewing the target sequence, known function, available PDB entries, prior modeling work, and the chemistry that has already been tried. The goal is to understand what the team already believes about the target, and where structural analysis can either confirm or challenge that view.
02
Structural Feasibility Assessment and Method Selection
Based on the target's size, flexibility, and history, we recommend the most realistic experimental or computational route. For some targets, crystallography is fast; for others, cryo-EM or modeling is the better choice. This step prevents teams from committing to a long crystallization campaign that the protein is unlikely to support.
03
Protein Sample Preparation or Computational Model Setup
We produce the protein samples needed for experimental work, or build the structural models needed for computational work. Construct design, expression system, and purification strategy are selected to give a sample or a model that is actually useful for the planned analysis.
04
Experimental Structure Determination or Computational Modeling
Structures are generated using the chosen platform: X-ray diffraction, cryo-EM, MicroED, NMR, SAXS, or a combination of modeling, docking, and molecular dynamics. For degrader programs, this often includes binary and ternary complex work, supported by our PROTAC ternary complex assay capabilities where appropriate.
05
Structural Validation and Feature Analysis
Every structure is validated against standard quality metrics, then annotated for the features that matter to degrader design: pocket geometry, surface lysines, conformational states, and any mutations or variants the team needs to consider. This is where raw structural data becomes a usable design resource.
06
Structural Interpretation and TPD Design Recommendations
We close the loop by translating the structural findings into concrete suggestions for the chemistry team, which may include the warhead library, ligand design, E3 pairing, or the next round of structural work. Recommendations are written for working scientists, not as a generic structural summary.
Need Support at a Particular Structural Analysis Stage?
Whether you have a protein sequence, an existing model, or experimental data to interpret, BOC Sciences can help define the next useful step.
Why Us
BOC Sciences Target Structural Analysis Advantages
Experienced Structural Biology and TPD Research Team
Our structural biologists and computational scientists have worked on a wide range of TPD-relevant targets, including kinases, transcription factors, epigenetic readers, and multi-domain assemblies. That experience shows up in the questions we ask at project intake and in how we interpret ambiguous structural data.
Integrated Experimental and Computational Capabilities
We do not treat experimental and computational work as separate silos. Crystallography, cryo-EM, MD simulations, and docking are used in combination, so a weak experimental signal can be backed up by a strong model, and a strong model can be validated against experimental data.
Customized Solutions for Challenging Protein Targets
Many TPD targets are difficult to express, crystallize, or model in their full form. We adjust construct design, tag strategy, and analytical route to match each target, instead of forcing every protein into the same workflow.
Responsive Scientific Support and Actionable Structural Insights
We deliver structural reports in a form that medicinal chemists, computational chemists, and biologists can all use. Every project includes a scientist-to-scientist discussion of the findings and practical suggestions for the next round of PROTAC design or modeling work.
Applications
Applications of Target Structural Analysis in TPD Development
TPD Target Feasibility Assessment and Prioritization
Before committing to a full degrader program, teams use structural analysis to judge whether a candidate target is realistic for TPD. We look at pocket availability, lysine exposure, and the likelihood of productive ternary complex formation, then help rank targets by structural tractability.
Target Ligand Discovery and Binding Pocket Identification
For targets without known ligands, structural analysis helps identify ligandable pockets and provides a foundation for virtual screening and fragment-based hit finding. Our work can be combined with PROTAC design based on bioinformatics for a more complete starting point.
Structure-Guided Degrader Design and Optimization
Once a lead series is in hand, structural analysis guides the next round of warhead, linker, and E3 modifications. By mapping the binding mode and ternary complex geometry, we help the team make rational changes that improve potency, selectivity, or E3 ligase ligand compatibility.
Target Mutation and Degradation Resistance Investigation
When degrader potency drops against a mutated target, structural analysis identifies whether the loss comes from lost warhead contacts, lost ternary complex geometry, or altered surface properties. This information is used to redesign the ligand or to plan the next experimental campaign.
Case Study
Case Studies: Target Structural Analysis for TPD Development
Project Background
A North American early-stage biotech was deciding between two epigenetic reader proteins, BRD4 and a closely related BRD family member, for a degrader program in acute myeloid leukemia research. Both targets had reported small-molecule binders, but the team did not know whether either protein had a pocket geometry that could support productive ternary complex formation, and they could not afford to run parallel degrader campaigns blindly.
Technical Challenges
Published BRD4 structures were dominated by acetyl-lysine mimetic ligands occupying the KAc pocket, which is useful for inhibition but may not represent the best geometry for a bifunctional degrader. In addition, the team wanted to know whether surface lysines were positioned in a way that supported ubiquitin transfer when an E3 ligase was recruited nearby.
BOC Sciences Solutions
- Multi-Conformer Structural Analysis: We generated apo and ligand-bound BRD4 structures using crystallography and molecular dynamics, then compared the conformation of the KAc pocket, the BET family-defining motifs, and the ZA channel across different states.
- Surface Lysine and E3 Geometry Mapping: We mapped solvent-accessible lysines on BRD4, calculated their distances to the KAc pocket, and simulated ternary complex formation with CRBN and VHL to judge which ligase gave a more realistic ubiquitin transfer geometry.
- Comparative Target Feasibility Report: The second BRD family member was modeled and analyzed in parallel. Pocket geometry, surface lysine distribution, and ternary complex stability were compared side by side, and an objective structural ranking was delivered to the client.
Project Outcomes
BOC Sciences showed that the KAc pocket on BRD4 was conformationally stable and supported clean ternary complex formation with CRBN, while the alternative family member had a more open pocket but less favorable surface lysine positioning. Three different pocket conformations were characterized for BRD4, and one was identified as the most productive for degrader chemistry. With this structural ranking, the client committed fully to BRD4, selected a CRBN-based strategy, and avoided a parallel degrader program that the structural data would not have supported.
Project Background
A European translational research group had an existing CRBN-based CDK9 PROTAC series that showed strong target degradation in biochemical assays but inconsistent cellular potency across different cell models. The team wanted to know whether the issue was at the level of the target structure, the warhead engagement, or the ternary complex geometry, so they could plan their next round of analog design more efficiently.
Technical Challenges
CDK9 is a challenging structural target because it functions as part of the P-TEFb complex and can adopt different conformational states depending on its binding partners. The client’s existing co-crystal data covered only the kinase domain, leaving open questions about the importance of cyclin T interaction and the geometry of the linker exit vector from the ATP pocket.
BOC Sciences Solutions
- Full-Length CDK9 Structural Modeling: We built a structural model of CDK9 in complex with cyclin T1 using published structural fragments, then used molecular dynamics to evaluate the conformational landscape relevant to degrader binding.
- Warhead Binding Mode Reanalysis: Existing PROTAC co-crystal data was re-examined to identify the actual linker exit vector from the ATP pocket, and alternative attachment vectors were modeled for comparison.
- Ternary Complex Geometry Comparison: We compared ternary complex models for five PROTAC analogs with different linker lengths and attachment points, focusing on whether the recruited CRBN could productively engage the surface of CDK9 in each case.
Project Outcomes
BOC Sciences found that the linker exit vector in the original PROTAC series pointed toward a region of CDK9 that clashed sterically with CRBN in the modeled ternary complex. Three alternative exit vectors were identified as more productive, and linker modifications based on these new vectors restored the expected geometry. Of the five analogs that were reanalyzed, two were shown to have fundamentally improved ternary complex stability, and the client used the structural recommendation to design the next round of analogs rather than continuing the previous SAR direction.
Frequently Asked Questions (FAQ)
How Does Target Structural Analysis Guide Protein Degrader Design?
Target structural analysis reveals the three-dimensional organization of a protein, including its functional domains, ligand-binding pockets, and surface features. These insights help researchers identify regions suitable for ligand discovery and evaluate how binding pocket geometry, chemical properties, and surrounding residues may influence ligand design. For PROTAC development, structural information can also help identify solvent-exposed positions that may accommodate linker attachment and guide the selection of potential linker orientations. Conformational analysis may reveal additional binding opportunities that are not apparent in a single static structure. However, structural information provides a foundation for degrader design rather than direct evidence of degradation activity. Target engagement, E3 ligase recruitment, and cellular degradation assays are needed to confirm degrader performance.
Which Methods Are Suitable for Challenging Protein Structures?
Selecting an appropriate structural analysis method depends on protein size, stability, flexibility, membrane association, and the specific research question. X-ray crystallography can provide detailed atomic structures when suitable protein crystals are available. Cryo-electron microscopy is useful for many large protein complexes and targets that are difficult to crystallize, while nuclear magnetic resonance spectroscopy can characterize suitable proteins and their dynamic behavior in solution. Hydrogen-deuterium exchange mass spectrometry and small-angle X-ray scattering provide complementary information about conformational changes, solvent accessibility, and overall molecular shape. For targets without experimentally determined structures, AI-based structure prediction, homology modeling, and molecular dynamics simulations offer additional approaches. Combining experimental and computational methods can provide a more complete understanding of challenging protein targets.
Can Protein Structural Analysis Predict Target Degradability?
Protein structural analysis provides valuable insights into target degradability, but a three-dimensional structure alone cannot reliably determine whether a protein can be degraded. Structural analysis can identify potential ligand-binding pockets, solvent-exposed regions, accessible lysine residues, and conformational constraints that may influence degrader design. These features help researchers evaluate structural feasibility and prioritize targets for further investigation. However, successful degradation also depends on productive E3 ligase recruitment, the spatial organization of the degrader-induced complex, cellular localization, ubiquitination, and proteasomal recognition. Surface lysine accessibility does not necessarily establish an actual ubiquitination site. Therefore, structural analysis should be combined with target engagement, degradation activity, and mechanistic assays to develop a more reliable assessment of target degradability.
How Does BOC Sciences Customize Target Structural Analysis Projects?
BOC Sciences develops customized structural analysis strategies based on the target protein, available research data, and the specific objectives of each TPD project. Our scientists begin by reviewing protein sequences, domain organization, existing structural information, sample characteristics, and the structural questions that need to be addressed. We then determine whether the project would benefit from experimental structure determination, computational modeling, or an integrated approach. For challenging proteins with flexible regions, complex domain arrangements, or limited structural information, the analytical strategy can be adapted to the target's characteristics. We also consider available ligand and degrader data when defining the study scope. This approach helps clients obtain structural insights relevant to target prioritization, ligand discovery, and degrader optimization.
What Structural Analysis Results Can BOC Sciences Provide?
Depending on project requirements and technical feasibility, BOC Sciences can provide experimentally determined protein structures or computational structural models, together with detailed structural characterization results. These may include protein domain maps, ligand-binding pocket identification, key residue analysis, surface accessibility assessment, conformational comparisons, and structural evaluation of protein variants. For TPD development, our scientists can further interpret potential ligand-binding regions, linker attachment opportunities, and structural features relevant to degrader design. We distinguish experimentally supported observations from computational predictions and explain important limitations of the results. The findings are organized into practical reports with recommendations for additional studies, helping clients make informed decisions about target evaluation, ligand selection, and structure-guided degrader optimization.
Testimonials
Client Testimonials on Target Structural Analysis
Reliable Protein Structure Characterization
"Our target had been difficult to crystallize for years, and we were not sure a workable structure was realistic in the short term. BOC Sciences combined cryo-EM, crystallography of a domain construct, and a careful full-length model, and the final package was far more useful than anything we had tried internally."
— Dr. Reynolds, Principal Investigator at a US-based Translational Research Group
Precise Binding Pocket Insights
"What we appreciated most was that the team did not just hand us a structure. They mapped every relevant pocket, flagged which one actually supported ternary complex formation, and explained why the others would not work. That kind of interpretation is what our chemistry team needed."
— Dr. Lefevre, Senior Computational Chemist at a European Pharmaceutical Company
Effective Solutions for Challenging Targets
"We were told our target was too flexible for crystallography. BOC Sciences designed a construct that locked down the relevant state and produced a structure that was directly useful for our degrader campaign. It changed the trajectory of the program."
— Dr. Andersen, Structural Biology Lead at a Nordic Biotech Company
Responsive Support for Structure-Guided Design
"Every time we ran into a new design question, the structural team was quick to come back with an answer we could actually act on. The recommendations were specific, and the modeling files were clean enough to drop straight into our internal design tools."
— Ms. Chen, Project Manager at an Asia-Pacific Oncology-Focused Research Institute
* PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
BOC Sciences Support
Please contact us with any specific requirements and we will get back to you as soon as possible.
